DUSTIN SHEA: Open Payments
NPI 1245361195 · FOUNTAIN VALLEY, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,457 in 69 payments from 13 companies in 2025. Trend: 2023 $1,824 · 2024 $5,567 · 2025 $2,457
Food & beverage: $2,457
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 25 | $753 |
| Madrigal Pharmaceuticals | 9 | $540 |
| Gilead Sciences, Inc. | 10 | $324 |
| Janssen Biotech, Inc. | 10 | $318 |
| Medtronic, Inc. | 1 | $143 |
| Boston Scientific Corporation | 2 | $114 |
| PFIZER INC. | 2 | $54 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $46 |
| Aimmune Therapeutics, Inc. | 2 | $43 |
| Phathom Pharmaceuticals, Inc. | 3 | $43 |
Products named: REZDIFFRA, SKYRIZI, TREMFYA, RINVOQ, CREON, BARRX, Livdelzi, OverStitch Endoscopic Suturing System.
Industry payments across CA — which companies pay providers there.
